ARTICLE | Product Development
Gates, Wellcome Trust and Mastercard commit $125M to COVID-19 therapies
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 10, 2020 10:05 PM UTC
Updated on Mar 25, 2020 at 7:12 PM UTC
The Bill & Melinda Gates Foundation, Wellcome Trust and Mastercard Tuesday announced that they will team up to invest up to $125 million to fund a COVID-19 Therapeutics Accelerator to speed the development of therapies for the coronavirus.
The accelerator will focus on short-term solutions by identifying opportunities to repurpose agents that could be deployed rapidly, and on longer-term approaches such as developing new investigational drugs and antibody-based therapies. ...